Florence Joulain

Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes

Deepak L. Bhatt, Andrew Briggs, Shelby D. Reed et al. · Journal of the American College of Cardiology · 2020 · 63 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy

Eric Van Cutsem, Florence Joulain, Paulo M. Hoff et al. · Targeted Oncology · 2015 · 47 citations

Medicine, Oncology, Pharmacotherapy +17

Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer

Florence Joulain, Irina Proskorovsky, Carmen J. Allegra et al. · British Journal of Cancer · 2013 · 36 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI

Ian Chau, Florence Joulain, Sheikh Usman Iqbal et al. · BMC Cancer · 2014 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

The Role of Gender and Other Factors as Predictors of Not Receiving Reperfusion Therapy and of Outcome in ST-Segment Elevation Myocardial Infarction

Marc Cohen, Gian Franco Gensini, Frans Maritz et al. · Journal of Thrombosis and Thrombolysis · 2005 · 35 citations · Full text

Medicine, Cardiology, Clinical Cardiology +13